Califf Has Several Industry Ties To Sever Before Joining FDA
This article was originally published in The Tan Sheet
Executive Summary
Duke cardiologist has an equity stake in two companies and consulting arrangements with at least seven others.
You may also be interested in...
Potential For Califf’s Second Term As US FDA Commissioner Surprises, Excites Stakeholders
Many supporters believe Robert Califf checks all the boxes, but if nominated he would also face many familiar confirmation challenges.
Potential For Califf’s Second US FDA Commissioner Term Surprises, Excites Stakeholders
Many supporters believe Robert Califf checks all the boxes, but if nominated he would also face many familiar confirmation challenges.
Hahn May Not Run Into Questions About Industry Ties Like His Predecessors
Nominee for US FDA commissioner has remained largely focused on academic work and private practice, receiving only a few payments from pharma and device companies.